Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akio Iwanami

Showing results (81-90 of 98) with videos related to

Pageof 10
Sort By:
The Journal of Clinical Investigation|January 7, 2010
Heart failure causes cholinergic transdifferentiation of cardiac sympathetic nerves via gp130-signaling cytokines in rodentsHideaki Kanazawa, Masaki Ieda, Kensuke Kimura, et al.
The Journal of Biological Chemistry|March 20, 2014
Epithelial membrane protein-2 (EMP2) activates Src protein and is a novel therapeutic target for glioblastomaYu Qin, Maoyong Fu, Masamichi Takahashi, et al.
Molecular Brain|September 20, 2016
Pathological classification of human iPSC-derived neural stem/progenitor cells towards safety assessment of transplantation therapy for CNS diseasesKeiko Sugai, Ryuji Fukuzawa, Tomoko Shofuda, et al.
Nature Medicine|November 14, 2006
A selective Sema3A inhibitor enhances regenerative responses and functional recovery of the injured spinal cordShinjiro Kaneko, Akio Iwanami, Masaya Nakamura, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 27, 2013
PML mediates glioblastoma resistance to mammalian target of rapamycin (mTOR)-targeted therapiesAkio Iwanami, Beatrice Gini, Ciro Zanca, et al.
Science Translational Medicine|April 28, 2012
mTOR inhibitors synergize on regression, reversal of gene expression, and autophagy in hepatocellular carcinomaHala Elnakat Thomas, Carol A Mercer, Larissa S Carnevalli, et al.
Cell Metabolism|October 22, 2013
mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-MycKenta Masui, Kazuhiro Tanaka, David Akhavan, et al.
Plos One|August 23, 2016
Prevalence and Distribution of Ossified Lesions in the Whole Spine of Patients with Cervical Ossification of the Posterior Longitudinal Ligament A Multicenter Study (JOSL CT study)Takashi Hirai, Toshitaka Yoshii, Akio Iwanami, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 24, 2010
The phosphatase and tensin homolog regulates epidermal growth factor receptor (EGFR) inhibitor response by targeting EGFR for degradationIgor Vivanco, Daniel Rohle, Matthias Versele, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 2012
Resistance to EGF receptor inhibitors in glioblastoma mediated by phosphorylation of the PTEN tumor suppressor at tyrosine 240Tim R Fenton, David Nathanson, Claudio Ponte de Albuquerque, et al.
Pageof 10

Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
The Journal of Clinical Investigation|January 7, 2010
Heart failure causes cholinergic transdifferentiation of cardiac sympathetic nerves via gp130-signaling cytokines in rodentsHideaki Kanazawa, Masaki Ieda, Kensuke Kimura, et al.
The Journal of Biological Chemistry|March 20, 2014
Epithelial membrane protein-2 (EMP2) activates Src protein and is a novel therapeutic target for glioblastomaYu Qin, Maoyong Fu, Masamichi Takahashi, et al.
Molecular Brain|September 20, 2016
Pathological classification of human iPSC-derived neural stem/progenitor cells towards safety assessment of transplantation therapy for CNS diseasesKeiko Sugai, Ryuji Fukuzawa, Tomoko Shofuda, et al.
Nature Medicine|November 14, 2006
A selective Sema3A inhibitor enhances regenerative responses and functional recovery of the injured spinal cordShinjiro Kaneko, Akio Iwanami, Masaya Nakamura, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 27, 2013
PML mediates glioblastoma resistance to mammalian target of rapamycin (mTOR)-targeted therapiesAkio Iwanami, Beatrice Gini, Ciro Zanca, et al.
Science Translational Medicine|April 28, 2012
mTOR inhibitors synergize on regression, reversal of gene expression, and autophagy in hepatocellular carcinomaHala Elnakat Thomas, Carol A Mercer, Larissa S Carnevalli, et al.
Cell Metabolism|October 22, 2013
mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-MycKenta Masui, Kazuhiro Tanaka, David Akhavan, et al.
Plos One|August 23, 2016
Prevalence and Distribution of Ossified Lesions in the Whole Spine of Patients with Cervical Ossification of the Posterior Longitudinal Ligament A Multicenter Study (JOSL CT study)Takashi Hirai, Toshitaka Yoshii, Akio Iwanami, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 24, 2010
The phosphatase and tensin homolog regulates epidermal growth factor receptor (EGFR) inhibitor response by targeting EGFR for degradationIgor Vivanco, Daniel Rohle, Matthias Versele, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 2012
Resistance to EGF receptor inhibitors in glioblastoma mediated by phosphorylation of the PTEN tumor suppressor at tyrosine 240Tim R Fenton, David Nathanson, Claudio Ponte de Albuquerque, et al.
Pageof 10